ClinicalThought

Share

Program Content

Activities

  • ImmunoTx in Bladder Cancer
    Expert Answers to Frequently Asked Questions on Immunotherapy for Patients With Bladder Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 18, 2020

    Expires: August 17, 2021

Faculty

cover img faculity

Matthew I. Milowsky, MD

Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

cover img faculity

Daniel P. Petrylak, MD

Professor of Medicine
Smilow Cancer Center
Yale University Medical Center
New Haven, Connecticut

cover img faculity

Jonathan Rosenberg, MD

Attending Physician, Chief
Genitourinary Oncology Service
Division of Solid Tumor Oncology
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Astellas Seattle Genetics

QED Therapeutics